A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy
John R. North(Inimex Pharmaceuticals (Canada)), Oreola Donini(Soligenix (United States)), Steven M. Opal(Brown University), B. Brett Finlay(University of British Columbia), Agnieszka Kielczewska(McGill University Health Centre), Annett Rozek(Inimex Pharmaceuticals (Canada)), Lisa A. Morici(Tulane University), Richard Straube, Christopher J. Schaber(Soligenix (United States)), Shunsuke Takenaka(Inimex Pharmaceuticals (Canada))
Cited by 30
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k